Hexarelin vs GHRP-6
How do Hexarelin and GHRP-6 compare for Growth Hormone Axis research? Side-by-side evidence, molecular profile, EU legal status and COA-verified supplier prices — never dosing advice.
At a glance
Hexarelin
GHRP-6
Which fits which research target?
Both Hexarelin and GHRP-6 sit within Growth Hormone Axis research but are studied for different primary signals. Neither is an approved medicine — compare the evidence, not marketing claims.
What the research shows
Hexarelin
Human studies confirm potent GH release with desensitisation upon repeated dosing — a characteristic that limits sustained use research. Cardiac research: in rat ischaemia-reperfusion models, hexarelin reduced infarct size and improved contractile function via a GH-independent mechanism (CD36 receptor). The cardioprotective profile is a distinct research angle compared to other GHRPs.
GHRP-6
Compare prices across EU suppliers
Compare Hexarelin across EU suppliers
1 EU vendors · COA · from €59
Compare GHRP-6 across EU suppliers
3 EU vendors · COA · from €29.99
Frequently asked questions
Is Hexarelin or GHRP-6 better? ▾
Neither is an approved medicine, and “better” depends on the research target. Hexarelin is most associated with Growth Hormone Axis, while GHRP-6 is studied for GH secretion. Compare the evidence tiers and COA-verified EU pricing above rather than assuming one is superior. This is not a usage recommendation.
Why compare Hexarelin and GHRP-6? ▾
Both are studied within Growth Hormone Axis research through different mechanisms, so researchers often weigh them against each other. This page sets their evidence, molecular profile, EU legal status and supplier pricing side by side.
Which is cheaper in the EU, Hexarelin or GHRP-6? ▾
Prices vary by supplier, vial size and COA status. Hexarelin is listed from €59 across 1 COA-verified EU vendors; GHRP-6 from €29.99 across 3. Open the price pages above to compare current listings — nobody pays us for placement.